Indeed, we found that blocking TGFβ1 with anti-TGFβ1 antibody could reduce the phosphorylation of ERK and AKT in pancreatic cancer, while treating with TGFβ1 protein showed the opposed effect. The gene discussed is TGFB1; the disease is pancreatic neoplasm.